Pathstone Holdings’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.81M Sell
159,684
-64,395
-29% -$2.88M 0.02% 529
2026
Q1
$10.8M Sell
224,079
-15,813
-7% -$737K 0.04% 321
2025
Q4
$11.6M Buy
239,892
+18,495
+8% +$917K 0.04% 293
2025
Q3
$10.4M Buy
221,397
+8,936
+4% +$431K 0.04% 324
2025
Q2
$10.3M Sell
212,461
-2,108
-1% -$108K 0.04% 320
2025
Q1
$11.9M Buy
214,569
+7,674
+4% +$415K 0.05% 282
2024
Q4
$9.98M Buy
206,895
+37,937
+22% +$1.93M 0.04% 313
2024
Q3
$9.74M Sell
168,958
-255
-0.2% -$13.8K 0.04% 332
2024
Q2
$8.21M Buy
169,213
+7,723
+5% +$373K 0.04% 365
2024
Q1
$7.85M Buy
161,490
+38,620
+31% +$1.89M 0.04% 377
2023
Q4
$6.11M Buy
+122,870
New +$6.01M 0.03% 381

Other funds holding SNY

Pathstone Holdings's SNY Position: Q2 2026 in Review

Pathstone Holdings reduced its Sanofi (SNY) stake by 29% in Q2 2026, selling an estimated $2.88M and leaving 159,684 shares worth $6.81M. The position accounts for 0.02% of the portfolio, ranked #529.

Pathstone Holdings first reported a position in SNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.9M in Q1 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Pathstone Holdings held 159,684 shares of Sanofi worth $6.81M as of Q2 2026.
  • Pathstone Holdings sold 64,395 Sanofi shares in Q2 2026, an estimated $2.88M.
  • Sanofi made up 0.02% of Pathstone Holdings's portfolio in Q2 2026, its #529 holding.
  • Pathstone Holdings first reported a position in Sanofi in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Sanofi position peaked at $11.9M in Q1 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.